The Breadth and Potency of Passively Acquired Human Immunodeficiency Virus Type 1-Specific Neutralizing Antibodies Do Not Correlate with the Risk of Infant Infection

Although a major goal of human immunodeficiency virus type 1 (HIV-1) vaccine efforts is to elicit broad and potent neutralizing antibodies (NAbs), there are no data that directly demonstrate a role for such NAbs in protection from HIV-1 infection in exposed humans. The setting of mother-to-child tra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lynch, John B., Nduati, Ruth, Blish, Catherine A., Richardson, Barbra A., Mabuka, Jennifer M., Jalalian-Lechak, Zahra, John-Stewart, Grace, Overbaugh, Julie
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Pathogenesis and Immunity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3094986/
https://ncbi.nlm.nih.gov/pubmed/21411521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02216-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados